mrna-3705
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 6, 2021 (NCT04899310)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Methylmalonyl-CoA mutase, mitochondrialSupplementation
supplementation - mmut
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05295433 | Phase 1/Phase 2 (Phase 2) | Mar 8, 2022 | Moderna Therapeutics |
| NCT04899310 | Phase 1/Phase 2 (Phase 2) | Aug 6, 2021 | Moderna Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moderna Therapeutics | For profit | 2 | 2 | 1 | 2021 |
1 organizations
Page 1 / 1